Meng‐Lei Huan

992 total citations
36 papers, 824 citations indexed

About

Meng‐Lei Huan is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Meng‐Lei Huan has authored 36 papers receiving a total of 824 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Biomaterials and 8 papers in Biomedical Engineering. Recurrent topics in Meng‐Lei Huan's work include Nanoparticle-Based Drug Delivery (9 papers), RNA Interference and Gene Delivery (7 papers) and Advanced biosensing and bioanalysis techniques (7 papers). Meng‐Lei Huan is often cited by papers focused on Nanoparticle-Based Drug Delivery (9 papers), RNA Interference and Gene Delivery (7 papers) and Advanced biosensing and bioanalysis techniques (7 papers). Meng‐Lei Huan collaborates with scholars based in China, United States and India. Meng‐Lei Huan's co-authors include Siyuan Zhou, Bang‐Le Zhang, Qibing Mei, Zenghui Teng, Han Cui, Daozhou Liu, Miao Liu, Ning Wan, Yiyang Jia and Zhifu Yang and has published in prestigious journals such as PLoS ONE, Biomaterials and Journal of Agricultural and Food Chemistry.

In The Last Decade

Meng‐Lei Huan

35 papers receiving 818 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Meng‐Lei Huan 323 187 144 77 71 36 824
Piergiorgio Pettazzoni 316 1.0× 138 0.7× 100 0.7× 60 0.8× 50 0.7× 13 772
Haining Tan 360 1.1× 134 0.7× 117 0.8× 69 0.9× 63 0.9× 51 888
Elham Ghasemipour Afshar 410 1.3× 162 0.9× 179 1.2× 72 0.9× 29 0.4× 15 921
Prashanth K.B. Nagesh 429 1.3× 317 1.7× 254 1.8× 126 1.6× 42 0.6× 32 1.1k
Qunyou Tan 438 1.4× 170 0.9× 140 1.0× 122 1.6× 37 0.5× 48 1.0k
Bilan Wang 257 0.8× 340 1.8× 161 1.1× 67 0.9× 28 0.4× 14 878
Dhanalekshmi Unnikrishnan Meenakshi 450 1.4× 143 0.8× 118 0.8× 47 0.6× 42 0.6× 45 1.3k
Davoud Jafari-Gharabaghlou 355 1.1× 204 1.1× 152 1.1× 122 1.6× 30 0.4× 42 871
Shih-Chang Tsai 445 1.4× 113 0.6× 59 0.4× 78 1.0× 45 0.6× 24 805

Countries citing papers authored by Meng‐Lei Huan

Since Specialization
Citations

This map shows the geographic impact of Meng‐Lei Huan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng‐Lei Huan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng‐Lei Huan more than expected).

Fields of papers citing papers by Meng‐Lei Huan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meng‐Lei Huan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng‐Lei Huan. The network helps show where Meng‐Lei Huan may publish in the future.

Co-authorship network of co-authors of Meng‐Lei Huan

This figure shows the co-authorship network connecting the top 25 collaborators of Meng‐Lei Huan. A scholar is included among the top collaborators of Meng‐Lei Huan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meng‐Lei Huan. Meng‐Lei Huan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Tingting, et al.. (2025). Tumor-targeted nano-delivery system of camptothecin nanocrystals for the effective treatment of triple negative breast cancer. Journal of Pharmaceutical Sciences. 114(10). 103951–103951.
2.
Cheng, Ying, Zhifu Yang, Qifeng Ji, et al.. (2024). Glioma-targeted oxaliplatin/ferritin clathrate reversing the immunosuppressive microenvironment through hijacking Fe2+ and boosting Fenton reaction. Journal of Nanobiotechnology. 22(1). 93–93. 12 indexed citations
3.
Huan, Meng‐Lei, et al.. (2024). Construction of the pulmonary bio-adhesive delivery system of nintedanib nanocrystalline for effective treatment of pulmonary fibrosis. International Journal of Pharmaceutics. 660. 124302–124302. 3 indexed citations
4.
Huan, Meng‐Lei, et al.. (2023). Construction of mPEI/pGPX4 gene therapeutic system for the effective treatment of acute lung injury. Nanotechnology. 34(33). 335101–335101. 3 indexed citations
5.
Li, Jiaxin, et al.. (2023). Bone targeted miRNA delivery system for miR-34a with enhanced anti-tumor efficacy to bone-associated metastatic breast cancer. International Journal of Pharmaceutics. 635. 122755–122755. 5 indexed citations
6.
Huan, Meng‐Lei, et al.. (2023). Tumor targeted combination therapeutic system for the effective treatment of drug resistant triple negative breast cancer. International Journal of Pharmaceutics. 636. 122821–122821. 12 indexed citations
7.
Zhang, Yaowen, Hua Li, Wei Wang, et al.. (2022). The regulatory role and mechanism of autophagy in energy metabolism-related hepatic fibrosis. Pharmacology & Therapeutics. 234. 108117–108117. 21 indexed citations
8.
9.
Wang, Wei, Yiyang Jia, Meng‐Lei Huan, et al.. (2020). Polyethylenimine-based nanovector grafted with mannitol moieties to achieve effective gene delivery and transfection. Nanotechnology. 31(32). 325101–325101. 13 indexed citations
10.
Wan, Ning, Meng‐Lei Huan, Ziwei Jing, et al.. (2017). Design and application of cationic amphiphilic β-cyclodextrin derivatives as gene delivery vectors. Nanotechnology. 28(46). 465101–465101. 7 indexed citations
11.
Zhao, Yuan, Meng‐Lei Huan, Miao Liu, et al.. (2016). Doxorubicin and resveratrol co-delivery nanoparticle to overcome doxorubicin resistance. Scientific Reports. 6(1). 35267–35267. 96 indexed citations
12.
Jing, Ziwei, Yiyang Jia, Ning Wan, et al.. (2016). Design and evaluation of novel pH-sensitive ureido-conjugated chitosan/TPP nanoparticles targeted to Helicobacter pylori. Biomaterials. 84. 276–285. 91 indexed citations
13.
Huan, Meng‐Lei, Ning Wan, Yilin Hou, et al.. (2016). Cholesterol derived cationic lipids as potential non-viral gene delivery vectors and their serum compatibility. Bioorganic & Medicinal Chemistry Letters. 26(10). 2401–2407. 21 indexed citations
14.
Liu, Hongfei, Ning Wan, Meng‐Lei Huan, et al.. (2014). Enhanced water-soluble derivative of PC407 as a novel potential COX-2 inhibitor injectable formulation. Bioorganic & Medicinal Chemistry Letters. 24(20). 4794–4797. 2 indexed citations
15.
Wang, Xiaojuan, Han Cui, Rong Wang, et al.. (2012). Metabolism and Pharmacokinetic Study of Ardipusilloside I in Rats. Planta Medica. 78(6). 565–574. 6 indexed citations
16.
Huan, Meng‐Lei, Bang‐Le Zhang, Zenghui Teng, et al.. (2012). In Vitro and In Vivo Antitumor Activity of a Novel pH-Activated Polymeric Drug Delivery System for Doxorubicin. PLoS ONE. 7(9). e44116–e44116. 23 indexed citations
17.
Huan, Meng‐Lei, Han Cui, Zenghui Teng, et al.. (2012). In VivoAnti-Tumor Activity of a New Doxorubicin Conjugateviaα-Linolenic Acid. Bioscience Biotechnology and Biochemistry. 76(8). 1577–1579. 18 indexed citations
18.
Zhang, Bang‐Le, Wei He, Xin Shi, et al.. (2010). Synthesis and biological activity of the calcium modulator (R) and (S)-3-methyl 5-pentyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate. Bioorganic & Medicinal Chemistry Letters. 20(3). 805–808. 23 indexed citations
19.
Huan, Meng‐Lei, Siyuan Zhou, Zenghui Teng, et al.. (2009). Conjugation with α-linolenic acid improves cancer cell uptake and cytotoxicity of doxorubicin. Bioorganic & Medicinal Chemistry Letters. 19(9). 2579–2584. 25 indexed citations
20.
Shang, Fujun, Ru Jiang, Li Liu, et al.. (2007). Nitric Oxide-Donating Genistein Prodrug: Design, Synthesis, and Bioactivity on MC3T3-E1 Cells. Journal of Pharmacological Sciences. 104(1). 82–89. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026